Lajkosz K - Search Results

1

CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis.

Wohlmuth C, Djedovic V, Kjaer SK, Jensen A, Glasspool R, Roxburgh P, DeFazio A, Johnatty SE, Webb PM, Modugno F, Lambrechts D, Schildkraut JM, Berchuck A, Thomsen LCV, Bjorge L, Høgdall E, Høgdall CK, Goode EL, Winham SJ, Matsuo K, Karlan BY, Lester J, Goodman MT, Thompson PJ, Pejovic T, Riggan MJ, Lajkosz K, Tone A, May T. Wohlmuth C, et al. Among authors: lajkosz k. Cancers (Basel). 2022 Apr 13;14(8):1954. doi: 10.3390/cancers14081954. Cancers (Basel). 2022. PMID: 35454861 Free PMC article.

2

Understanding the clinical implication of mismatch repair deficiency in endometrioid endometrial cancer through a prospective study.

Kim SR, Tone A, Kim RH, Cesari M, Clarke BA, Eiriksson L, Hart T, Aronson M, Holter S, Lytwyn A, Lajkosz K, Oldfield L, Gallinger S, Bernardini MQ, Oza AM, Djordjevic B, Lerner-Ellis J, Van de Laar E, Vicus D, Pugh T, Pollett A, Ferguson SE. Kim SR, et al. Among authors: lajkosz k. Gynecol Oncol. 2021 Apr;161(1):221-227. doi: 10.1016/j.ygyno.2021.01.002. Epub 2021 Jan 19. Gynecol Oncol. 2021. PMID: 33478752

3

Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification.

Olkhov-Mitsel E, Yu Y, Lajkosz K, Liu SK, Vesprini D, Sherman CG, Downes MR. Olkhov-Mitsel E, et al. Among authors: lajkosz k. Cancers (Basel). 2022 Oct 7;14(19):4911. doi: 10.3390/cancers14194911. Cancers (Basel). 2022. PMID: 36230835 Free PMC article.

4

Statin Use and Survival Among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic Review and Meta-analysis.

Jayalath VH, Clark R, Lajkosz K, Fazelzad R, Fleshner NE, Klotz LH, Hamilton RJ. Jayalath VH, et al. Among authors: lajkosz k. JAMA Netw Open. 2022 Nov 1;5(11):e2242676. doi: 10.1001/jamanetworkopen.2022.42676. JAMA Netw Open. 2022. PMID: 36449294 Free PMC article.

5

Comprehensive molecular assessment of mismatch repair deficiency in Lynch associated ovarian cancers using next generation sequencing panel.

Kim SR, Oldfield L, Tone A, Pollett A, Pedersen S, Wellum J, Cesari M, Lajkosz K, Pugh TJ, Ferguson SE. Kim SR, et al. Among authors: lajkosz k. Int J Gynecol Cancer. 2024 Feb 5;34(2):267-276. doi: 10.1136/ijgc-2023-004815. Int J Gynecol Cancer. 2024. PMID: 37940339

6

T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.

White LM, Atinga A, Naraghi AM, Lajkosz K, Wunder JS, Ferguson P, Tsoi K, Griffin A, Haider M. White LM, et al. Among authors: lajkosz k. Skeletal Radiol. 2023 Mar;52(3):553-564. doi: 10.1007/s00256-022-04098-2. Epub 2022 Jul 1. Skeletal Radiol. 2023. PMID: 35778618

7

Characterization and management of NMIBC recurrences after TMT: a matched cohort analysis.

Ajib K, Berjaoui MB, Herrera-Caceres J, Nason G, Tan GH, Tjong MC, Lajkosz K, Sridhar S, Fleshner NE, Zlotta AR, Catton C, Berlin A, Chung P, Kulkarni GS. Ajib K, et al. Among authors: lajkosz k. Urol Oncol. 2021 Dec;39(12):835.e1-835.e7. doi: 10.1016/j.urolonc.2021.05.008. Epub 2021 Jun 13. Urol Oncol. 2021. PMID: 34134928

8

Factors Associated with Stent Change and Prognosis in Patients with Malignant Ureteral Obstruction.

Gandhi S, Koziarz A, Finelli A, Fleshner N, Hamilton RJ, Kulkarni G, Perlis N, Zlotta A, Lajkosz K, Lee JY. Gandhi S, et al. Among authors: lajkosz k. J Endourol. 2022 Aug;36(8):1083-1090. doi: 10.1089/end.2021.0956. Epub 2022 Jun 2. J Endourol. 2022. PMID: 35331023

9

The prognostic value of urinary cytology after trimodal therapy (TMT) for muscle-invasive bladder cancer.

McLoughlin LC, O'Halloran S, Tjong M, Ajib K, Lajkosz K, Ruff H, Lou S, Chung P, Raman S, Kulkarni GS, Zlotta AR, Fleshner NE, Berlin A. McLoughlin LC, et al. Among authors: lajkosz k. Urol Oncol. 2022 Jul;40(7):346.e9-346.e16. doi: 10.1016/j.urolonc.2022.02.021. Epub 2022 Apr 4. Urol Oncol. 2022. PMID: 35393232

10

The Impact of CD34⁺ Cell Collection Yields for Autologous Transplant on Survival Outcomes in Multiple Myeloma.

Lebel E, Lajkosz K, Masih-Khan E, Reece D, Trudel S, Tiedemann R, Prica A, Kukreti V, Chen C. Lebel E, et al. Among authors: lajkosz k. Clin Lymphoma Myeloma Leuk. 2023 Nov;23(11):850-856. doi: 10.1016/j.clml.2023.07.014. Epub 2023 Aug 14. Clin Lymphoma Myeloma Leuk. 2023. PMID: 37689547 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters